Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 172.30 BATS BZX Real-Time Price As of 1:12pm ET |  +0.08 / +0.05%Today’s Change | 21.83 Today|||52-Week Range 172.35 | +353.54% Year-to-Date |
Latest RETA News | Press Releases
| Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? Sep 18 / Zacks.com - Paid Partner Content | Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy? Sep 09 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 172.22 |
| Today’s open | 172.29 |
| Day’s range | 172.24 - 172.35 |
| Volume | 37,883 |
| Average volume (3 months) | 915,254 |
| Market cap | $6.6B |
Data as of 1:12pm ET, 09/21/2023
Growth & Valuation
| Earnings growth (last year) | -4.32% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -80.71% |
| P/E ratio | NM |
| Price/Sales | 626.04 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KRTXKaruna Therapeutics ... | -5.03 | -2.89% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 1:01pm ET, 09/21/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$2.33 |
| Annual revenue (last year) | $2.2M |
| Annual profit (last year) | -$311.9M |
| Net profit margin | -14,074.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plano, Texas |
Forecasts
